British Journal of Clinical Pharmacology

Introduction
pp. 1-4(4)
Authors: Boffito, Marta; Abel, Samantha

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers
pp. 5-18(14)
Authors: Abel, Samantha; van der Ryst, Elna; Rosario, Maria C.; Ridgway, Caroline E.; Medhurst, Christine G.; Taylor-Worth, Richard J.; Muirhead, Gary J.

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers
pp. 19-26(8)
Authors: Abel, Samantha; Russell, Deborah; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Muirhead, Gary J.

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
pp. 27-37(11)
Authors: Abel, Samantha; Russell, Deborah; Taylor-Worth, Richard J.; Ridgway, Caroline E.; Muirhead, Gary J.

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
pp. 38-46(9)
Authors: Abel, Samantha; Jenkins, Timothy M.; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Muirhead, Gary J.

The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers
pp. 47-53(7)
Authors: Abel, Samantha; Russell, Deborah; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Muirhead, Gary J.

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects
pp. 54-59(6)
Authors: Pozniak, Anton L.; Boffito, Marta; Russell, Deborah; Ridgway, Caroline E.; Muirhead, Gary J.

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects
pp. 60-67(8)
Authors: Abel, Samantha; Russell, Deborah; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Nedderman, Angus N. R.; Walker, Donald K.

Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects
pp. 68-75(8)
Authors: Davis, John D.; Hackman, Frances; Layton, Gary; Higgins, Tracy; Sudworth, David; Weissgerber, Georges

A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects
pp. 76-85(10)
Authors: Chan, Phylinda L. S.; Weatherley, Barry; McFadyen, Lynn

Population pharmacokinetic/ pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients
pp. 86-94(9)
Authors: Rosario, Maria C.; Jacqmin, Philippe; Dorr, Pat; James, Ian; Jenkins, Timothy M.; Abel, Samantha; van der Ryst, Elna

A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc
pp. 95-106(12)
Authors: Jacqmin, Philippe; McFadyen, Lynn; Wade, Janet R.